For the Inventor, By the Inventor

Enter assignee name

Fujisawa Pharmaceutical Company, Ltd.

USPTO Granted Patents = 940

CIPO Patents = 5

EPO Patents = 1

Trademarks = 5

Forward Citations = 10,649

Loading Chart...

Loading Chart...

816 inventors (with patents filed for the assignee):

Takao Takaya (149 out of 149 patents)

Hisashi Takasugi (134 out of 137 patents)

Masashi Hashimoto (100 out of 186 patents)

4. Teruo Kyoto Oku (88 out of 88 patents)

5. Hirokazu Tanaka (76 out of 76 patents)

6. Tsutomu Toyonaka Teraji (76 out of 77 patents)

7. Ikuo Ueda (56 out of 59 patents)

8. Takashi Kamiya (55 out of 56 patents)

9. Kazuo Sakane (54 out of 54 patents)

10. Takashi Masugi (50 out of 50 patents)

11. Keiji Hemmi (46 out of 48 patents)

12. Masayoshi Murata (44 out of 44 patents)

13. Masaaki Matsuo (42 out of 42 patents)

14. Kohji Kawabata (40 out of 43 patents)

15. Hiroshi Kayakiri (40 out of 40 patents)

Core Competencies:

Aminoalcohol Derivatives

Imidazole Compounds

Amyloid Beta Protein

Liposome Preparations

Thiazepinyl Hydroxamic Acid

Cyclic Hexapeptide Derivatives

Immunosuppressants

Benzimidazole Derivatives

Sustained Release Formulations

Antimicrobial Activity

Phosphodiesterase Inhibitors

Fat Promoting Agents

940 patents: Sort by Forward Citations

1. 7629366 - Aminoalcohol derivatives (2009-12-08),

2. 7060721 - Imidazole compounds and medicinal use thereof (2006-06-13),

3. 7029860 - Amyloid-β protein aggregation-regulating factors (2006-04-18),

4. 6984397 - Liposome preparations (2006-01-10),

5. 6979461 - Method for producing liposome preparation (2005-12-27),

6. 6967197 - Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors (2005-11-22),

7. 6960435 - Amyloid β protein agglutination-controlling factor (2005-11-01),

8. 6927230 - Triazole derivatives (2005-08-09),

9. 6924278 - Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists (2005-08-02),

10. 6911469 - Sulfonamide compounds and pharmaceutical use thereof (2005-06-28),

11. 6908940 - Imidazole compounds and their use as adenosine deaminase inhibitors (2005-06-21),

12. 6890934 - Sulfonamide compounds and uses thereof as medicines (2005-05-10),

13. 6890909 - Brain-protective agent (2005-05-10),

14. 6884868 - Cyclic hexapeptides having antibiotic activity (2005-04-26),

15. 6884774 - Cyclic hexapeptide derivatives (2005-04-26),

Fujisawa Pharmaceutical Company, Ltd. is a Japanese pharmaceutical company, now merged into Astellas Pharma. They are focused on the research, development, manufacture, and sales of medical products. Visit their website to learn more about their innovative healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

940 Patents

#28 in Osaka

#233 in Japan

#1,057 in the World

Fujisawa Pharmaceutical Company, Ltd.

Forward Citations = 10,649

816 inventors:

Takao Takaya (149 out of 149 patents)

Hisashi Takasugi (134 out of 137 patents)

Masashi Hashimoto (100 out of 186 patents)

4. Teruo Kyoto Oku (88 out of 88 patents)

5. Hirokazu Tanaka (76 out of 76 patents)

Please report any incorrect information to support@idiyas.com

Loading…